Navigation Links
Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer

t could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials and research and development programs, the regulatory approval process for clinical trials, competitive technologies and products, patents, continuation of corporate partnerships and the need for additional financings. For information about these and other risks which may affect Cell Genesys, please see the company's Annual Report on Form 10-K for the year ended December 31, 2006 filed on March 1, 2007 as well as Cell Genesys' reports on Form 10-Q and 8-K and other reports filed from time to time with the Securities and Exchange Commission. The company assumes no obligation to update the forward-looking information in this press release.

    Contact:  Ina Cu

    Investor Relations

    650-266-3200


CONTACT: Ina Cu, Investor Relations of Cell Genesys, Inc., +1-650-266-3200

Web site: http://www.cellgenesys.com/

Ticker Symbol: (NASDAQ-NMS:CEGE)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
2. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. XTL Provides Update on Phase I Clinical Trial of XTL-2125
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
9. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
10. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
11. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
Post Your Comments:
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), a ... products principally for use in the hospital setting, today ... September 30, 2011 financial results on Thursday, November 3, ... conference call and live webcast to discuss the financial ...
... FRAMINGHAM, Mass. and SYDNEY, Oct. 27, 2011 HeartWare ... a leading innovator of less invasive, miniaturized circulatory support ... failure, announced today that David McIntyre, Chief Financial Officer ... family back to Australia for personal reasons and will ...
Cached Medicine Technology:HeartWare International Announces Planned Departure of Chief Financial Officer 2HeartWare International Announces Planned Departure of Chief Financial Officer 3HeartWare International Announces Planned Departure of Chief Financial Officer 4
(Date:5/25/2015)... 24Hr HomeCare is proud to announce that David Allerby, ... Ryan Iwamoto, Co-Founder & CMO, are Finalists for the ... in Greater Los Angeles. The award is presented by ... performance, and a personal commitment to their communities. , ... success of our organization,” said Co-Founder & CEO, David ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 ProDrop Light Show ... own VJ neon light backdrops with a click of a mouse. ... and much more all within Final Cut Pro X. , ProDrop ... such as drop zones, kaleidoscope and much more leaving infinite possibilities ... Show drop zones and text presets, users can apply their ...
(Date:5/25/2015)... Decora Preset 60 Minute Countdown Timer , a product ... City.’ The product helps in automatically switching off any electronic ... related electronic device is automatically turned off after the set ... “We are glad that this amazing product is now available ... Switch in just a few clicks. The product has been ...
(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... allow them to take pressure measurements in patients’ bladder ... The doctor usually orders it if they have reported ... (OAB). , Women’s Excellence in Bladder Control ... with unwanted urinary leakage or problems with overall control ...
(Date:5/24/2015)... Indiana (PRWEB) May 24, 2015 Indiana ... service provider announces Midwest Telecom of America, Inc. (MTA) ... , According to Cory Childs, IFN Enterprise Sales Manager, ... service providers. “IFN’s fiber transport provides MTA with ... Center to their Tier 1 Internet and voice carriers ...
Breaking Medicine News(10 mins):Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2
... The American Heart Association recognized several distinguished volunteers and ... The Cure on the Hill Awards Luncheon" and "Gold ... presented its Gold Heart Award to Scott M. Grundy, ... M.D. The award is the organization,s highest volunteer honor, ...
... why people suffer mood disorder after discharge , , TUESDAY, ... depression in people after they,ve been hospitalized in an ... researchers. , Their study involved 160 people who,d been ... that typically requires invasive interventions, including the use of ...
... 21 BullMarket.com ( http://www.bullmarket.com ), ... stocks, has provided subscribers with coverage of medical device and ... Gen-Probe (Nasdaq: GPRO ), St. Jude Medical (NYSE: ... and Synovis (Nasdaq: SYNO ), among others.All paid ...
... could save upwards of $35 billion over ten years if ... and post-acute care, said Avalere Health in a new report ... assess the federal costs of change in long-term care policy, ... Congressional Budget Office. Using the model, Avalere assessed a ...
... Hudson Institute is pleased to welcome Tevi Troy, most ... Human Services (HHS) under George W. Bush, as a ... on health care, medical innovation, and bio-defense issues. "With ... we are very fortunate to have someone of Dr. ...
... A scientist whose work is key to understanding how cancer ... advances in his latest research at a public forum to ... Fry, of the Department of Biochemistry, leads a renowned research ... as a leading laboratory in the field of Molecular Cell ...
Cached Medicine News:Health News:Association Honors Top Volunteers, Staff Member at Washington, D.C. Meeting 2Health News:Association Honors Top Volunteers, Staff Member at Washington, D.C. Meeting 3Health News:Organ Failure, Sedative Use in ICU May Lead to Depression 2Health News:BullMarket.com Updates Outlook on Medical Device and Equipment Stocks 2Health News:Reform of Long-Term Care System Could Save Billions 2Health News:Former HHS Deputy Secretary Tevi Troy Joins Hudson Institute 2Health News:New advances in cancer research to be highlighted at University of Leicester 2
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm....
18 gauge tapered fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Set consist of two 27 gauge, stainless steel probes with blunt tips. Probes are 11.5 cm (4.5 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto th...
Curved, soft flexible tip allows atraumatic entry through a retinal tear or hole for aspiration of subretinal fluids. 20 gauge x 25 mm cannula attached to 25 gauge x 6 mm tip with 13 mm flexible tubi...
Medicine Products: